The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
New-onset refractory status epilepticus: Etiology, clinical features, and outcome
Open accessAbstract
OBJECTIVES: The aims of this study were to determine the etiology, clinical features, and predictors of outcome of new-onset refractory status epilepticus. METHODS: Retrospective review of patients with refractory status epilepticus without etiology identified within 48 hours of admission between January 1, 2008, and December 31, 2013, in 13 academic medical centers. The primary outcome measure was poor functional outcome at discharge (defined as a score >3 on the modified Rankin Scale). RESULTS: Of 130 cases, 67 (52%) remained cryptogenic. The most common identified etiologies were autoimmune (19%) and paraneoplastic (18%) encephalitis. Full data were available in 125 cases (62 cryptogenic). Poor outcome occurred in 77 of 125 cases (62%), and 28 (22%) died. Predictors of poor outcome included duration of status epilepticus, use of anesthetics, and medical complications. Among the 63 patients with available follow-up data (median 9 months), functional status improved in 36 (57%); 79% had good or fair outcome at last follow-up, but epilepsy developed in 37% with most survivors (92%) remaining on antiseizure medications. Immune therapies were used less frequently in cryptogenic cases, despite a comparable prevalence of inflammatory CSF changes. CONCLUSIONS: Autoimmune encephalitis is the most commonly identified cause of new-onset refractory status epilepticus, but half remain cryptogenic. Outcome at discharge is poor but improves during follow-up. Epilepsy develops in most cases. The role of anesthetics and immune therapies warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Self-citationIrani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Refractory Status Epilepticus: Frequency, Risk Factors, and Impact on Outcome
Mayer, S. A., Claassen, J., Lokin, J., Mendelsohn, F., Dennis, L. J., & Fitzsimmons, B.-F. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.205 · Cited by 658
Self-citationDeterminants of Mortality in Status Epilepticus
Towne, A. R., Pellock, J. M., Ko, D., & DeLorenzo, R. J. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02908.x · Cited by 653
Beyond Viruses: Clinical Profiles and Etiologies Associated with Encephalitis
Glaser, C. A., Honarmand, S., Anderson, L. J., Schnurr, D. P., Forghani, B., Cossen, C. K., Schuster, F. L., Christie, L. J., & Tureen, J. H. (2006) · Clinical Infectious Diseases · doi:10.1086/509330 · Cited by 650
Incidence of status epilepticus in Rochester, Minnesota, 1965-1984
Hesdorffer, D. C., Logroscino, G., Cascino, G., Annegers, J. F., & Hauser, W. A. (1998) · Neurology · doi:10.1212/wnl.50.3.735 · Cited by 494
EFNS guideline on the management of status epilepticus in adults
Meierkord, H., Boon, P., Engelsen, B., Göcke, K., Shorvon, S., Tinuper, P., & Holtkamp, M. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02917.x · Cited by 433
Cited by
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
Abboud, H., Probasco, J. C., Irani, S., Ances, B., Benavides, D. R., Bradshaw, M., Christo, P. P., Dale, R. C., Fernandez-Fournier, M., Flanagan, E. P., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325300 · Cited by 554
Self-citationHirsch, L. J., Gaspard, N., van Baalen, A., Nabbout, R., Demeret, S., Loddenkemper, T., Navarro, V., Specchio, N., Lagae, L., Rossetti, A. O., et al. (2018) · Epilepsia · doi:10.1111/epi.14016 · Cited by 540
Self-citationInterleukin 6: at the interface of human health and disease
Grebenciucova, E., & VanHaerents, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1255533 · Cited by 281
Gaspard, N., Hirsch, L. J., Sculier, C., Loddenkemper, T., van Baalen, A., Lancrenon, J., Emmery, M., Specchio, N., Farias‐Moeller, R., Wong, N., et al. (2018) · Epilepsia · doi:10.1111/epi.14022 · Cited by 277
Self-citationSteriade, C., Britton, J., Dale, R. C., Gadoth, A., Irani, S. R., Linnoila, J., McKeon, A., Shao, X., Venegas, V., & Bien, C. G. (2020) · Epilepsia · doi:10.1111/epi.16571 · Cited by 265
Metadata
- Authors
- Gaspard, N., Foreman, B. P., Alvarez, V., Cabrera Kang, C., Probasco, J. C., Jongeling, A. C., Meyers, E., Espinera, A., Haas, K. F., Schmitt, S. E., Gerard, E. E., Gofton, T., Kaplan, P. W., Lee, J. W., Legros, B., Szaflarski, J. P., Westover, B. M., LaRoche, S. M., Hirsch, L. J., For the Critical Care EEG Monitoring Research Consortium (CCEMRC), Critical Care EEG Monitoring Research Consortium (CCEMRC), Fertig, E., Herman, S. T., Huh, L., Lee, J. W., Loddenkemper, T., Chapman, K., Abend, N. S., Carpenter, J., Hantus, S., Claassen, J., Husain, A. M., Gaspard, N., LaRoche, S. M., Ritzl, E. K., Gofton, T., Wusthoff, C., Goldstein, J., Westover, B. M., Hocker, S., Halford, J., Jones, J., Gerard, E. E., Schmitt, S. E., Williams, K., Hahn, C. D., Szaflarski, J. P., Kramer, A., Rudzinski, L., Hopp, J., Mani, R., Kalamangalam, G. P., Gupta, P., Quigg, M. S., Haas, K. F., Ostendorf, A., Zutshi, D., & Hirsch, L. J.
- Venue
- Neurology
- Published
- 2015-11-03
- Volume
- 85
- Issue
- 18
- Pages
- 1604-1613
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1887067355
- Cited by
- 488
- References
- 24
- FWCI
- 23.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New-onset refractory status epilepticus: Etiology, clinical features, and outcome. https://app.cochat.ai/papers/10.1212/wnl.0000000000001940
- The paper
- Gaspard, N., Foreman, B. P., Alvarez, V., Cabrera Kang, C., Probasco, J. C., Jongeling, A. C., Meyers, E., Espinera, A., Haas, K. F., Schmitt, S. E., Gerard, E. E., Gofton, T., Kaplan, P. W., Lee, J. W., Legros, B., Szaflarski, J. P., Westover, B. M., LaRoche, S. M., Hirsch, L. J., . . . Hirsch, L. J. (2015). New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology. https://doi.org/10.1212/wnl.0000000000001940
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.